Trials / Completed
CompletedNCT03719287
Study to Estimate the Point Prevalence of Peripheral Intravenous Catheter-related Complications in Brazil
National, Cross-sectional, Multicenter Study to Estimate the Point Prevalence of Peripheral Intravenous Catheter-related Complications in Brazil: a Quality Improvement Study (PIVS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 295 (actual)
- Sponsor
- Solventum US LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
A multi-center, national prevalence study where: (1) baseline SPIVC therapy complications of hospitalized adult patients that meet the inclusion/exclusion criteria of the study and (2) the compliance of clinicians to the Hospital's evidence based practice will be measured in Brazil.
Detailed description
At each participating research site, select nurse clinicians who are experienced or experts in short peripheral I.V. catheter (SPIVC) therapy, will audit medical records and observe the SPIVC sites of adult patients in various hospital wards until a minimum total of 300 SPIVC sites are audited among 3 Brazilian acute care hospitals. The wards audited will be selected by the Investigator and will be audited during a specified time period until at least 100 SPIVCs are audited. The time to complete the study will depend on the size of the select wards, the number of nurse auditors and the number of monitoring visits required. There are no treatments. The short peripheral I.V. catheter-related medical devices (products) observed during the study are currently approved by Brazil regulatory agencies, purchased by the hospital and available to the clinician at the time of the study.
Conditions
Timeline
- Start date
- 2019-01-07
- Primary completion
- 2019-07-31
- Completion
- 2019-10-01
- First posted
- 2018-10-25
- Last updated
- 2024-10-02
- Results posted
- 2022-08-02
Locations
3 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03719287. Inclusion in this directory is not an endorsement.